Suppr超能文献

血清IgG4/IgG水平与Graves眼病发生发展的相关性研究

Study on the correlation between serum IgG4/IgG levels and the development of Graves' ophthalmopathy.

作者信息

Deng Yuanyuan, Hao Zejin, Li Shanshan, Zhang Junping, Zhang Jie, Gan Huaxia, Cai Wei, Liu Yang, Xu Jixiong

机构信息

Department of Endocrinology and Metabolism, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17 Yongwaizheng St, Nanchang, 330006, Jiangxi Province, People's Republic of China.

Jiangxi clinical research center for endocrine and metabolic disease, Nanchang, 330006, People's Republic of China.

出版信息

Sci Rep. 2025 Jan 22;15(1):2770. doi: 10.1038/s41598-025-87126-0.

Abstract

Graves' ophthalmopathy (GO) with elevated IgG4 levels has different characteristics from patients with GO who do not have elevated IgG4 levels, but the study findings are contradictory. The goal of this study was first to investigate the relationship between IgG4/IgG and IgG4 levels and the occurrence of GO and then to investigate the clinical and laboratory characteristics of patients with GO who had elevated IgG4 levels. This study control group consisted of 57 Graves' disease(GD)patients with no complicated ocular disease and a median followup of 54.41 months, while the experimental group included 171 GO patients. The clinical and laboratory characteristics of the GD and GO groups were compared. Using an IgG4/IgG cut-off value of 8%, the GO patients were divided into two groups: high IgG4/IgG and low IgG4/IgG, and the differences in clinical and laboratory characteristics between these two groups, as well as between the GO patients before and after 3 months of treatment, were analyzed. The study results show that serum IgG4/IgG levels were independently correlated with the occurrence of GO, but not significantly correlated with GO activity. Patients with high IgG4/IgG levels of GO exhibit distinct characteristics, which may be associated with an unstable balance of lymphocyte subsets.

摘要

IgG4水平升高的格雷夫斯眼病(GO)与IgG4水平未升高的GO患者具有不同特征,但研究结果相互矛盾。本研究的目的首先是调查IgG4/IgG和IgG4水平与GO发生之间的关系,然后调查IgG4水平升高的GO患者的临床和实验室特征。本研究对照组由57例无复杂眼部疾病的格雷夫斯病(GD)患者组成,中位随访时间为54.41个月,而实验组包括171例GO患者。比较了GD组和GO组的临床和实验室特征。使用8%的IgG4/IgG临界值,将GO患者分为两组:高IgG4/IgG组和低IgG4/IgG组,并分析了这两组之间以及GO患者治疗3个月前后的临床和实验室特征差异。研究结果表明,血清IgG4/IgG水平与GO的发生独立相关,但与GO活动无显著相关性。GO患者中IgG4/IgG水平高的患者表现出不同的特征,这可能与淋巴细胞亚群的不稳定平衡有关。

相似文献

2
Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.
Thyroid. 2017 Sep;27(9):1185-1193. doi: 10.1089/thy.2017.0126.
3
IgG4 serum levels in Graves' orbitopathy.
J Endocrinol Invest. 2024 Jul;47(7):1711-1717. doi: 10.1007/s40618-023-02265-3. Epub 2023 Dec 21.
4
Clinical Significance of IgG4 Serum Concentration in Graves' Disease.
Arch Immunol Ther Exp (Warsz). 2024 Jul 20;72(1). doi: 10.2478/aite-2024-0015. eCollection 2024 Jan 1.
5
Serum Immunoglobulin G4 levels are elevated in patients with Graves' ophthalmopathy.
Clin Endocrinol (Oxf). 2015 Dec;83(6):962-7. doi: 10.1111/cen.12671. Epub 2014 Dec 12.
6
7
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.
J Endocrinol Invest. 2019 Apr;42(4):471-480. doi: 10.1007/s40618-018-0943-8. Epub 2018 Aug 21.
8
Ocular Manifestations and Clinical Implications of Serum Immunoglobulin G4 Levels in Graves' Ophthalmopathy Patients.
Ocul Immunol Inflamm. 2022 Apr 3;30(3):580-587. doi: 10.1080/09273948.2020.1826537. Epub 2020 Oct 15.
9
Clinical relevance of serum immunoglobulin G4 in glucocorticoid therapy of Graves' ophthalmopathy.
Clin Endocrinol (Oxf). 2021 Oct;95(4):657-667. doi: 10.1111/cen.14493. Epub 2021 Jul 16.
10
Serum immunoglobulin G4 levels and Graves' disease phenotype.
Endocrine. 2017 Feb;55(2):478-484. doi: 10.1007/s12020-016-1157-5. Epub 2016 Nov 7.

引用本文的文献

1
Sheehan's syndrome complicated with Graves' disease in a woman with a 20-year history of hypothyroidism.
J Int Med Res. 2025 Aug;53(8):3000605251363777. doi: 10.1177/03000605251363777. Epub 2025 Aug 6.

本文引用的文献

1
IgG4 serum levels in Graves' orbitopathy.
J Endocrinol Invest. 2024 Jul;47(7):1711-1717. doi: 10.1007/s40618-023-02265-3. Epub 2023 Dec 21.
2
Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy.
Open Life Sci. 2023 Aug 31;18(1):20220694. doi: 10.1515/biol-2022-0694. eCollection 2023.
3
The phenotype of Graves' orbitopathy is associated with thyrotropin receptor antibody levels.
J Endocrinol Invest. 2023 Nov;46(11):2309-2317. doi: 10.1007/s40618-023-02085-5. Epub 2023 Apr 5.
4
Identification of risk factors for elevated serum IgG4 levels in subjects in a large-scale health checkup cohort study.
Front Immunol. 2023 Mar 8;14:1124417. doi: 10.3389/fimmu.2023.1124417. eCollection 2023.
5
High IgG4 serum concentration is associated with active Graves orbitopathy.
Front Endocrinol (Lausanne). 2023 Mar 1;14:1083321. doi: 10.3389/fendo.2023.1083321. eCollection 2023.
6
Current concepts regarding Graves' orbitopathy.
J Intern Med. 2022 Nov;292(5):692-716. doi: 10.1111/joim.13524. Epub 2022 Jun 1.
7
The characteristics and clinical significance of elevated serum IgG4/IgG levels in patients with Graves' disease.
Endocrine. 2022 Mar;75(3):829-836. doi: 10.1007/s12020-021-02935-3. Epub 2021 Nov 13.
9
Thyroid Eye Disease: Navigating the New Treatment Landscape.
J Endocr Soc. 2021 Mar 17;5(5):bvab034. doi: 10.1210/jendso/bvab034. eCollection 2021 May 1.
10
Clinical features and clinical course of thyroid-associated ophthalmopathy: a case series of 3620 Chinese cases.
Eye (Lond). 2021 Aug;35(8):2294-2301. doi: 10.1038/s41433-020-01246-7. Epub 2020 Nov 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验